Inulin (Chicory Root Fiber)
Chicory-derived fructan prebiotic — bifidogenic, modest glycemic and lipid effects, boosts calcium absorption
What is Inulin (Chicory Root Fiber)?
Inulin (Chicory Root Fiber) (Fructan · Cichorium intybus) is a prebiotic fiber used for bifidogenic prebiotic: selectively increases bifidobacterium and boosts colonic short-chain fatty acid (scfa) production, the most consistently reproduced effect in human trials. NutriDex grades the human evidence as Moderate. Inulin is a non-digestible fructan (chains of fructose with a terminal glucose) extracted mainly from chicory root (Cichorium intybus); it resists upper-gut digestion and is fermented in the colon to short-chain fatty acids, selectively expanding Bifidobacterium. The strongest human evidence is for its bifidogenic prebiotic effect and for modest glycemic benefit in prediabetes/type 2 diabetes (a GRADE-assessed dose-response meta-analysis of 33 RCTs found significant reductions in fasting glucose, HbA1c, insulin, and HOMA-IR). Effects on LDL/triglycerides, body weight, and constipation are real but small and of low-to-moderate certainty, while calcium-absorption and bone-mineralization benefits are well demonstrated in adolescents. Inulin is a fermentable FODMAP, so dose-dependent gas and bloating are its main practical limitation.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Bifidogenic prebiotic effect (↑Bifidobacterium, ↑SCFA)Most consistently reproduced effect across human trials; well-replicated bifidogenic shift. | Strong | ↑ benefit · moderate | 2 |
| Glycemic control in prediabetes/T2D (fasting glucose, HbA1c, HOMA-IR)GRADE-assessed meta-analysis of 33 RCTs; benefit concentrated in prediabetic/diabetic populations, ~10 g/day for 6+ weeks. | Strong | ↑ benefit · moderate | 2 |
| Lipid lowering (LDL, triglycerides)Meta-analyses show small LDL/TG reductions of low-to-very-low certainty; larger effects in type 2 diabetes. | Moderate | ↑ benefit · small | 2 |
| Constipation relief / increased stool frequencyCrossover RCTs at ~12 g/day raise stool frequency in low-frequency subjects, but it is a fermentable FODMAP causing gas. | Moderate | ↑ benefit · small | 2 |
| Modest weight loss / satietyMeta-analysis shows ~1 kg loss vs placebo; oligofructose RCT lowered ghrelin and raised PYY. | Moderate | ↑ benefit · small | 2 |
| Calcium absorption and bone mineralizationWell-demonstrated in adolescents (8 g/day raised calcium absorption and bone density), but largely a single population. | Moderate | ↑ benefit · moderate | 1 |